Article Details
Retrieved on: 2021-08-06 16:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic ...
Article found on: www.investorideas.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here